130 related articles for article (PubMed ID: 169365)
1. Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel.
Menczer J; Leventon-Kriss S; Modan M; Oelsner G; Gerichter CB
J Natl Cancer Inst; 1975 Jul; 55(1):3-6. PubMed ID: 169365
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
Seth P; Prakash SS; Ghosh D
Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
[TBL] [Abstract][Full Text] [Related]
3. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
4. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
Christenson B; Espmark A
Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
[TBL] [Abstract][Full Text] [Related]
6. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
[TBL] [Abstract][Full Text] [Related]
7. Selected epidemiological features of herpes genitalis in Israel based on laboratory data.
Smetana Z; Dulitzky M; Movshovitz M; Isacsohn M; Seidman D; Leventon-Kriss S
Isr J Med Sci; 1994; 30(5-6):375-9. PubMed ID: 8034486
[TBL] [Abstract][Full Text] [Related]
8. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
Seth P; Balachandran N
Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
[TBL] [Abstract][Full Text] [Related]
9. Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms.
Eglin RP; Sharp F; MacLean AB; Macnab JC; Clements JB; Wilkie NM
Cancer Res; 1981 Sep; 41(9 Pt 1):3597-603. PubMed ID: 6167349
[TBL] [Abstract][Full Text] [Related]
10. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
Smith JW; Torres JE; Holmquist ND
Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
[TBL] [Abstract][Full Text] [Related]
11. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
12. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 2 and human cervical cancer: relationship between cellular and immune assays for the detection of previous infection.
Smith JW; Torres JE; Holmquist ND
J Natl Cancer Inst; 1981 Jun; 66(6):1031-6. PubMed ID: 6941038
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
15. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
Gilman SC; Docherty JJ; Clarke A; Rawls WE
Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
[TBL] [Abstract][Full Text] [Related]
16. Herpesvirus type 2 in adenocarcinoma of the uterine cervix: a possible association.
Menczer J; Yaron-Schiffer O; Leventon-Kriss S; Modan M; Modan B
Cancer; 1981 Oct; 48(7):1497-9. PubMed ID: 7284955
[TBL] [Abstract][Full Text] [Related]
17. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
Jankowski MA; Petersen EE; Böcker JF
Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2 and carcinoma of cervix uteri.
Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
[No Abstract] [Full Text] [Related]
19. Herpesvirus infection and cervical anaplasia: a seroepidemiological study.
Choi NW; Shettigara PT; Abu-Zeid HA; Nelson NA
Int J Cancer; 1977 Feb; 19(2):167-71. PubMed ID: 190174
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
